Magnetic Resonance Imaging Market - Global Forecast 2025-2032

The Magnetic Resonance Imaging market is entering a transformative phase, supported by widespread adoption of advanced technologies that drive clinical, operational, and business value for health systems, imaging providers, and technology suppliers. Senior stakeholders face an evolving landscape where competitive differentiation increasingly hinges on both product innovation and strategic alignment with global healthcare trends.

Market Snapshot: Magnetic Resonance Imaging Market Overview

The Magnetic Resonance Imaging market grew from USD 6.12 billion in 2024 to USD 6.48 billion in 2025 and is forecast to continue expanding at a CAGR of 5.90%, reaching USD 9.69 billion by 2032. This sustained momentum is propelled by the growing importance of non-invasive diagnostics in modern medicine, the integration of machine learning into imaging workflows, and a sharp focus on patient-centered system upgrades. The market remains highly dynamic, with evolving procurement patterns and regulatory shifts influencing investment decisions worldwide.

Scope & Segmentation

Comprehensive segmentation unlocks a deeper understanding of demand patterns and innovation triggers across the Magnetic Resonance Imaging market:

• Product Types: Closed MRI, Open MRI
• Field Strengths: High Field, Low Field, Ultra-High Field
• Magnet Types: Permanent, Resistive, Superconducting
• Coil Types: Body Coil, Cardiac Coil, Extremity Coil, Head Coil
• Applications: Cardiovascular, Musculoskeletal, Neurology (with Brain and Spinal Cord Imaging), Oncology (Hematological Cancer Imaging, Solid Tumor Imaging)
• End Users: Academic and Research Institutes, Diagnostic Imaging Centers, Hospitals (including Private and Public Hospitals)
• Regions and Countries: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland, United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel, South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Major Companies: Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi, Ltd., Samsung Medison Co., Ltd., Fujifilm Holdings Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Esaote S.p.A., Neusoft Medical Systems Co., Ltd.

Key Takeaways for Decision-Makers

• Artificial intelligence and machine learning are redefining imaging workflows, helping streamline diagnostics and alleviate radiologist workload.
• Strategic collaborations between academic institutions, manufacturers, and healthcare providers accelerate the validation of new contrast agents and functional applications.
• Regulatory updates facilitate the introduction of cloud-based platforms and post-processing tools, enabling faster time-to-market for innovative solutions.
• Patient-centric designs, such as open MRI systems and advanced comfort features, address both operational throughput and clinical inclusivity, broadening potential user bases.
• Manufacturers are recalibrating supply chain strategies to manage procurement volatility and tariff exposure, with a notable shift toward regional manufacturing and vendor negotiations.

Tariff Impact: Navigating 2025 Market Dynamics

New United States tariffs taking effect in 2025 introduce major variables for global Magnetic Resonance Imaging supply chains and procurement operations. Elevated duties on raw materials and components have increased manufacturing costs, spurring a wave of supply chain localization and renegotiation with suppliers. In response, some providers have temporarily postponed equipment upgrades, while manufacturers diversify regional investment to minimize future tariff risks. These developments highlight the importance of resilient supply strategies and agile capital planning for stakeholders pursuing sustained growth.

Methodology & Data Sources

This report leverages a robust methodology combining primary interviews with industry experts and secondary analysis of peer-reviewed literature, regulatory filings, and proprietary market databases. Quantitative and qualitative findings are validated through scenario modeling and stakeholder panel review, ensuring the highest standards of analytical rigor and credibility for strategic planning.

Why This Report Matters

• Enables senior leaders to benchmark against current modalities, emerging technologies, and evolving procurement trends across geographies and end user groups.
• Supports evidence-based decision-making on capital allocation, partnership strategies, and technology adoption to maintain competitiveness in a maturing market.
• Delivers actionable intelligence on tariff impacts, regulatory trends, and supply chain considerations for improved risk mitigation and future readiness.

Conclusion

The Magnetic Resonance Imaging market continues to evolve through innovation, regulatory adaptation, and shifting end-user priorities. Stakeholders can harness these insights to refine strategy, drive sustainable growth, and shape the next era of diagnostic imaging excellence.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.